-
1 Comment
China SXT Pharmaceuticals, Inc is currently in a long term downtrend where the price is trading 16.7% below its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.3.
Finally, its free cash flow grew by 77.6% to $-226K since the same quarter in the previous year.
Based on the above factors, China SXT Pharmaceuticals, Inc gets an overall score of 2/5.
| ISIN | VGG2161P1320 |
|---|---|
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector | Healthcare |
| CurrencyCode | USD |
| Exchange | NASDAQ |
| Market Cap | 2M |
|---|---|
| Beta | 0.76 |
| Dividend Yield | 0.0% |
| Target Price | None |
| PE Ratio | None |
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for SXTC using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
